Open Label Extension of LipoLat-CS202

Completed

• Conditions: Glaucoma

• Registration Number: NCT02599688
• Lead Sponsor: Peregrine Ophthalmic

Brief Summary

This is an open-label, observational extension of patients who received POLAT-001 in LipoLat-CS202.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-11
• Study First Submitted: 2015-11-05
• Study First Submitted QC: 2015-11-05
• Study First Posted: 2015-11-06
• Primary Completion: 2016-06
• Study Completion: 2016-06
• Results First Submitted: 2020-09-08
• Status Verified: 2020-11
• Results First Submitted QC: 2020-11-18
• Last Update Submitted: 2020-11-18
• Results First Posted: 2020-12-14
• Last Update Posted: 2020-12-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 18

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Intraocular Pressure (IOP)	3 months	Mean change from baseline (Visit 1 in Study LipoLat-CS202, NCT02466399) IOP at Month 3 (6 months after treatment in LipoLat-CS202).

Trial Locations

Locations (1)

Professional Research Network; 🇺🇸 Goose Creek, South Carolina, United States